Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease

Abstract Neurodegeneration with brain iron accumulation (NBIA) represents a group of neurodegenerative disorders characterized by abnormal iron accumulation in the brain. In Parkinson’s Disease (PD), iron accumulation is a cardinal feature of degenerating regions in the brain and seems to be a key p...

Full description

Bibliographic Details
Main Authors: Pilar Alvarez Jerez, Jose Luis Alcantud, Lucia de los Reyes-Ramírez, Anni Moore, Clara Ruz, Francisco Vives Montero, Noela Rodriguez-Losada, Prabhjyot Saini, Ziv Gan-Or, Chelsea X. Alvarado, Mary B. Makarious, Kimberley J. Billingsley, Cornelis Blauwendraat, Alastair J. Noyce, Andrew B. Singleton, Raquel Duran, Sara Bandres-Ciga
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-023-00496-y
_version_ 1797417595056422912
author Pilar Alvarez Jerez
Jose Luis Alcantud
Lucia de los Reyes-Ramírez
Anni Moore
Clara Ruz
Francisco Vives Montero
Noela Rodriguez-Losada
Prabhjyot Saini
Ziv Gan-Or
Chelsea X. Alvarado
Mary B. Makarious
Kimberley J. Billingsley
Cornelis Blauwendraat
Alastair J. Noyce
Andrew B. Singleton
Raquel Duran
Sara Bandres-Ciga
author_facet Pilar Alvarez Jerez
Jose Luis Alcantud
Lucia de los Reyes-Ramírez
Anni Moore
Clara Ruz
Francisco Vives Montero
Noela Rodriguez-Losada
Prabhjyot Saini
Ziv Gan-Or
Chelsea X. Alvarado
Mary B. Makarious
Kimberley J. Billingsley
Cornelis Blauwendraat
Alastair J. Noyce
Andrew B. Singleton
Raquel Duran
Sara Bandres-Ciga
author_sort Pilar Alvarez Jerez
collection DOAJ
description Abstract Neurodegeneration with brain iron accumulation (NBIA) represents a group of neurodegenerative disorders characterized by abnormal iron accumulation in the brain. In Parkinson’s Disease (PD), iron accumulation is a cardinal feature of degenerating regions in the brain and seems to be a key player in mechanisms that precipitate cell death. The aim of this study was to explore the genetic and genomic connection between NBIA and PD. We screened for known and rare pathogenic mutations in autosomal dominant and recessive genes linked to NBIA in a total of 4481 PD cases and 10,253 controls from the Accelerating Medicines Partnership Parkinsons’ Disease Program and the UKBiobank. We examined whether a genetic burden of NBIA variants contributes to PD risk through single-gene, gene-set, and single-variant association analyses. In addition, we assessed publicly available expression quantitative trait loci (eQTL) data through Summary-based Mendelian Randomization and conducted transcriptomic analyses in blood of 1886 PD cases and 1285 controls. Out of 29 previously reported NBIA screened coding variants, four were associated with PD risk at a nominal p value < 0.05. No enrichment of heterozygous variants in NBIA-related genes risk was identified in PD cases versus controls. Burden analyses did not reveal a cumulative effect of rare NBIA genetic variation on PD risk. Transcriptomic analyses suggested that DCAF17 is differentially expressed in blood from PD cases and controls. Due to low mutation occurrence in the datasets and lack of replication, our analyses suggest that NBIA and PD may be separate molecular entities.
first_indexed 2024-03-09T06:20:58Z
format Article
id doaj.art-a74e40ce5b164c6c979708ea36164d99
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-09T06:20:58Z
publishDate 2023-04-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-a74e40ce5b164c6c979708ea36164d992023-12-03T11:43:25ZengNature Portfolionpj Parkinson's Disease2373-80572023-04-01911910.1038/s41531-023-00496-yExploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s diseasePilar Alvarez Jerez0Jose Luis Alcantud1Lucia de los Reyes-Ramírez2Anni Moore3Clara Ruz4Francisco Vives Montero5Noela Rodriguez-Losada6Prabhjyot Saini7Ziv Gan-Or8Chelsea X. Alvarado9Mary B. Makarious10Kimberley J. Billingsley11Cornelis Blauwendraat12Alastair J. Noyce13Andrew B. Singleton14Raquel Duran15Sara Bandres-Ciga16Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthInstitute of Neurosciences “Federico Olóriz”, Centro de Investigación Biomédica, Universidad de GranadaLaboratory of Neuropharmacology. Dept. Medicine and Life Sciences, Universitat Pompeu FabraMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthInstitute of Neurosciences “Federico Olóriz”, Centro de Investigación Biomédica, Universidad de GranadaInstitute of Neurosciences “Federico Olóriz”, Centro de Investigación Biomédica, Universidad de GranadaDepartment Human Physiology, Faculty of Medicine, Biomedicine Research Institute of Malaga (IBIMA C07), University of MalagaMontreal Neurological Institute, McGill UniversityMontreal Neurological Institute, McGill UniversityCenter for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of HealthMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of NeurologyMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthInstitute of Neurosciences “Federico Olóriz”, Centro de Investigación Biomédica, Universidad de GranadaMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of HealthAbstract Neurodegeneration with brain iron accumulation (NBIA) represents a group of neurodegenerative disorders characterized by abnormal iron accumulation in the brain. In Parkinson’s Disease (PD), iron accumulation is a cardinal feature of degenerating regions in the brain and seems to be a key player in mechanisms that precipitate cell death. The aim of this study was to explore the genetic and genomic connection between NBIA and PD. We screened for known and rare pathogenic mutations in autosomal dominant and recessive genes linked to NBIA in a total of 4481 PD cases and 10,253 controls from the Accelerating Medicines Partnership Parkinsons’ Disease Program and the UKBiobank. We examined whether a genetic burden of NBIA variants contributes to PD risk through single-gene, gene-set, and single-variant association analyses. In addition, we assessed publicly available expression quantitative trait loci (eQTL) data through Summary-based Mendelian Randomization and conducted transcriptomic analyses in blood of 1886 PD cases and 1285 controls. Out of 29 previously reported NBIA screened coding variants, four were associated with PD risk at a nominal p value < 0.05. No enrichment of heterozygous variants in NBIA-related genes risk was identified in PD cases versus controls. Burden analyses did not reveal a cumulative effect of rare NBIA genetic variation on PD risk. Transcriptomic analyses suggested that DCAF17 is differentially expressed in blood from PD cases and controls. Due to low mutation occurrence in the datasets and lack of replication, our analyses suggest that NBIA and PD may be separate molecular entities.https://doi.org/10.1038/s41531-023-00496-y
spellingShingle Pilar Alvarez Jerez
Jose Luis Alcantud
Lucia de los Reyes-Ramírez
Anni Moore
Clara Ruz
Francisco Vives Montero
Noela Rodriguez-Losada
Prabhjyot Saini
Ziv Gan-Or
Chelsea X. Alvarado
Mary B. Makarious
Kimberley J. Billingsley
Cornelis Blauwendraat
Alastair J. Noyce
Andrew B. Singleton
Raquel Duran
Sara Bandres-Ciga
Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
npj Parkinson's Disease
title Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
title_full Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
title_fullStr Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
title_full_unstemmed Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
title_short Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
title_sort exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for parkinson s disease
url https://doi.org/10.1038/s41531-023-00496-y
work_keys_str_mv AT pilaralvarezjerez exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT joseluisalcantud exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT luciadelosreyesramirez exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT annimoore exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT clararuz exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT franciscovivesmontero exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT noelarodriguezlosada exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT prabhjyotsaini exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT zivganor exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT chelseaxalvarado exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT marybmakarious exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT kimberleyjbillingsley exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT cornelisblauwendraat exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT alastairjnoyce exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT andrewbsingleton exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT raquelduran exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease
AT sarabandresciga exploringthegeneticandgenomicconnectionunderlyingneurodegenerationwithbrainironaccumulationandtheriskforparkinsonsdisease